A detailed history of Amica Mutual Insurance CO transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Amica Mutual Insurance CO holds 33,522 shares of BMY stock, worth $1.88 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
33,522
Previous 33,522 -0.0%
Holding current value
$1.88 Million
Previous $1.39 Million 24.57%
% of portfolio
0.17%
Previous 0.14%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

SELL
$40.25 - $52.99 $687,993 - $905,758
-17,093 Reduced 33.77%
33,522 $1.39 Million
Q2 2023

Aug 07, 2023

SELL
$63.71 - $70.74 $280,387 - $311,326
-4,401 Reduced 8.0%
50,615 $3.24 Million
Q1 2023

May 05, 2023

BUY
$65.71 - $74.53 $1.81 Million - $2.05 Million
27,502 Added 99.96%
55,016 $3.81 Million
Q1 2022

May 12, 2022

SELL
$61.48 - $73.72 $89,023 - $106,746
-1,448 Reduced 5.0%
27,514 $2.01 Million
Q4 2021

Feb 08, 2022

SELL
$53.63 - $62.52 $1.88 Million - $2.19 Million
-35,007 Reduced 54.72%
28,962 $1.81 Million
Q1 2021

May 07, 2021

SELL
$59.34 - $66.74 $219,083 - $246,404
-3,692 Reduced 5.46%
63,969 $4.04 Million
Q4 2020

Feb 10, 2021

SELL
$57.74 - $65.43 $960,216 - $1.09 Million
-16,630 Reduced 19.73%
67,661 $4.2 Million
Q4 2019

Feb 10, 2020

BUY
$49.21 - $64.19 $1.74 Million - $2.27 Million
35,364 Added 72.28%
84,291 $5.41 Million
Q1 2019

May 13, 2019

SELL
$45.12 - $53.8 $828,312 - $987,660
-18,358 Reduced 27.28%
48,927 $2.33 Million
Q4 2018

Feb 13, 2019

BUY
$48.76 - $63.23 $636,318 - $825,151
13,050 Added 24.06%
67,285 $3.5 Million
Q1 2018

May 11, 2018

SELL
$59.92 - $68.98 $2.06 Million - $2.38 Million
-34,438 Reduced 38.84%
54,235 $3.43 Million
Q2 2017

Aug 11, 2017

BUY
N/A
88,673
88,673 $4.94 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $120B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Amica Mutual Insurance CO Portfolio

Follow Amica Mutual Insurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amica Mutual Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Amica Mutual Insurance CO with notifications on news.